PubMed

Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis.

Doll DC, List AF, Greco FA, Hainsworth JD, Hande KR, Johnson DH.

Ann Intern Med. 1986 Jul;105(1):48-51.PMID: 2424354 [PubMed - indexed for MEDLINE]Related articles

Acute vascular toxicity after combination chemotherapy with cisplatin, vinblastine, and bleomycin for testicular cancer.

Stefenelli T, Kuzmits R, Ulrich W, Glogar D.

Eur Heart J. 1988 May;9(5):552-6.PMID: 2456930 [PubMed - indexed for MEDLINE]Related articles

Sequential trials of cisplatin, vinblastine, and bleomycin and etoposide and cisplatin in disseminated nonseminomatous germ cell tumors of the testis with a good prognosis at a single institution.

Germá JR, Sagarra AF, Izquierdo MA, Seguí MA.

Cancer. 1993 Feb 1;71(3):796-803.PMID: 7679314 [PubMed - indexed for MEDLINE]Related articles

A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.

Bosl GJ, Geller NL, Bajorin D, Leitner SP, Yagoda A, Golbey RB, Scher H, Vogelzang NJ, Auman J, Carey R, et al.

J Clin Oncol. 1988 Aug;6(8):1231-8.PMID: 2457657 [PubMed - indexed for MEDLINE]Related articles

Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.

Berger CC, Bokemeyer C, Schneider M, Kuczyk MA, Schmoll HJ.

Eur J Cancer. 1995 Dec;31A(13-14):2229-38.PMID: 8652248 [PubMed - indexed for MEDLINE]Related articles

Severe vascular toxicity associated with cisplatin-based chemotherapy.

Içli F, Karaoğuz H, Dinçol D, Demirkazik A, Günel N, Karaoğuz R, Uner A.

Cancer. 1993 Jul 15;72(2):587-93. Review.PMID: 8319192 [PubMed - indexed for MEDLINE]Related articles

Severe vascular toxicity associated with vinblastine, bleomycin, and cisplatin chemotherapy.

Samuels BL, Vogelzang NJ, Kennedy BJ.

Cancer Chemother Pharmacol. 1987;19(3):253-6.PMID: 2438065 [PubMed - indexed for MEDLINE]Related articles

Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.

Logothetis CJ, Samuels ML, Selig D, Swanson D, Johnson DE, von Eschenbach AC.

J Clin Oncol. 1985 Mar;3(3):326-35.PMID: 2579213 [PubMed - indexed for MEDLINE]Related articles

Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.

Westermann DH, Schefer H, Thalmann GN, Karamitopoulou-Diamantis E, Fey MF, Studer UE.

J Urol. 2008 Jan;179(1):163-6. Epub 2007 Nov 14.PMID: 18001800 [PubMed - indexed for MEDLINE]Related articles

Arterial occlusive events during chemotherapy for germ cell cancer.

Vos AH, Splinter TA, van der Heul C.

Neth J Med. 2001 Dec;59(6):295-9.PMID: 11744182 [PubMed - indexed for MEDLINE]Related articles

Cancer of the testis: a new paradigm.

Einhorn LH.

Hosp Pract (Off Ed). 1986 Apr 15;21(4):165-72, 175-8. Review. No abstract available. PMID: 2420812 [PubMed - indexed for MEDLINE]Related articles

Vascular toxicity following vinblastine, bleomycin, and cisplatin therapy for germ cell tumours.

Samuels BL, Vogelzang NJ, Kennedy BJ.

Int J Androl. 1987 Feb;10(1):363-9.PMID: 2438227 [PubMed - indexed for MEDLINE]Related articles

[Acute myocardial infarct following chemotherapy for testicular carcinoma: on the coronary toxicity of cytostatic agents]

Borek G, Gebel F, Jenzer HR.

Schweiz Med Wochenschr. 1991 Mar 16;121(11):385-9. Review. German. PMID: 1851325 [PubMed - indexed for MEDLINE]Related articles

Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors.

Culine S, Théodore C, Bekradda M, Farhat F, Terrier-Lacombe MJ, Droz JP.

Am J Clin Oncol. 1997 Apr;20(2):184-8.PMID: 9124197 [PubMed - indexed for MEDLINE]Related articles

[Treatment of advanced testicular cancer]

Murase T, Takashi M, Sobashima T, Shimoji T, Miyake K, Mitsuya H.

Hinyokika Kiyo. 1987 Jan;33(1):47-50. Japanese. PMID: 2437779 [PubMed - indexed for MEDLINE]Related articles

Vascular toxicity associated with chemotherapy for testicular cancer.

Gerl A.

Anticancer Drugs. 1994 Dec;5(6):607-14. Review.PMID: 7534146 [PubMed - indexed for MEDLINE]Related articles

Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols.

Nichols CR, Breeden ES, Loehrer PJ, Williams SD, Einhorn LH.

J Natl Cancer Inst. 1993 Jan 6;85(1):36-40.PMID: 7677934 [PubMed - indexed for MEDLINE]Related articles

Long-term complications of chemotherapy for germ cell tumours.

Chaudhary UB, Haldas JR.

Drugs. 2003;63(15):1565-77. Review.PMID: 12887263 [PubMed - indexed for MEDLINE]Related articles

[Chemotherapeutic effectiveness in malignant testicular tumors at advanced stages. Preliminary results of the VAB VI program]

Chiricuţă I, Ghilezan N.

Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir. 1985 Nov-Dec;34(6):455-68. Romanian. No abstract available. PMID: 2421373 [PubMed - indexed for MEDLINE]Related articles

Combination cisplatin, vinblastine, and bleomycin chemotherapy (PVB) for malignant germ-cell tumors of the ovary.

Carlson RW, Sikic BI, Turbow MM, Ballon SC.

J Clin Oncol. 1983 Oct;1(10):645-51.PMID: 6199468 [PubMed - indexed for MEDLINE]Related articles